J004-1653 Screening compound: 3-ethyl-5-{1-[5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]pyrrolidin-2-yl}-1,2-oxazole

J004-1653 Screening compound: 3-ethyl-5-{1-[5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]pyrrolidin-2-yl}-1,2-oxazole
J004-1653 Screening compound: 3-ethyl-5-{1-[5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]pyrrolidin-2-yl}-1,2-oxazole alternative view

Chemical Structure Depiction of ChemDiv screening compound J004-1653
3-ethyl-5-{1-[5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]pyrrolidin-2-yl}-1,2-oxazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J004-1653

Molecular Formula

C23H20F3N5O2 (C23 H20 F3 N5 O2)

Compound Name

3-ethyl-5-{1-[5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]pyrrolidin-2-yl}-1,2-oxazole

IUPAC name

3-ethyl-5-{1-[5-phenyl-7-(trifluoromethyl)pyrazolo[15-a]pyrimidine-3-carbonyl]pyrrolidin-2-yl}-12-oxazole

SMILES

CCc1noc(C(CCC2)N2C(c(cnn2c(C(F)(F)F)c3)c2nc3-c2ccccc2)=O)c1

InChI

InChI=1S/C23H20F3N5O2/c1-2-15-11-19(33-29-15)18-9-6-10-30(18)22(32)16-13-27-31-20(23(24,25)26)12-17(28-21(16)31)14-7-4-3-5-8-14/h3-5,7-8,11-13,18H,2,6,9-10H2,1H3/t18-/m0/s1

InChI Key

QGMKRASUWIPEQV-SFHVURJKSA-N

MDL Number (MFCD)

MFCD27215078

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.659

Distribution Coefficient, logD

4.659

Water Solubility, LogSw

-4.31

Polar Surface Area

57.907

Acid Dissociation Constant (pKa)

22.45

Base Dissociation Constant (pKb)

1.34

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.40

J004-1653 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with J004-1653 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J004-1653?
Check Price and Availability of J004-1653, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J004-1653 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J004-1653
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J004-1653
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J004-1653 available by request